First Hawaiian (NASDAQ:FHB) reported quarterly earnings of $0.46 per share which beat the analyst consensus estimate of $0.45 by 2.22 percent. This is a 32.35 percent decrease over earnings of $0.68 per share from the same period last year.
Citigroup Maintains Buy on Mirati Therapeutics, Lowers Price Target to $127
Citigroup analyst Yigal Nochomovitz maintains Mirati Therapeutics (NASDAQ:MRTX) with a Buy and lowers the price target from $208 to $127.